HomeAbout UsEditionsNewsContact UsAdvertiseAwardsSubscribe
Pitmans
   Log In
BM

Quick Links

Subscribe to our News feed

Abingdon: Green Biologics in merger

20 Jan 2012

GBL merges with US-based renewables company.

 

Green Biologics (GBL), a UK-based industrial biotechnology company has announced it has merged wit butylfuelTM Inc, a US-based renewable chemicals and biofuels company.

The new company will operate under the Green Biologics name and continue to be head- quartered in Abingdon, with a strong operational presence and commercial focus in the US contributed by butylfuelTM Inc, which will become Green Biologics, Inc.

The effective date for the all-equity merger is January 1, 2012.

“This merger creates a truly global leader in biobutanol and represents a transformational deal for both companies,” said Sean Sutcliffe, CEO of the combined GBL group. “ We are combining GBL’s acknowledged technology leadership and commercialization expertise in China, India and Brazil with the scale up, operational process experience, and North American business building capabilities of butylfuelTM.”

Joel Stone, President, North America and Global VP of Engineering, formerly CEO of butylfuelTM Inc, said: “This is a near perfect fit of a remarkable industrial biotechnology company in GBL with an experienced bioprocessing and commercial scale-up company in butylfuelTM Inc.”

He added: “The synergies of GBL’s microbiological and fermentation capabilities and global presence combined with our commercial and operational skills in building and operating large scale fermentation facilities in North America creates a compelling business model, in particular for the commercialization of biobutanol in North America, the world’s leading advanced renewable chemicals and biofuels market.”

The merged GBL will be a globally managed company focused on the production of C4 chemicals and advanced fuels from renewable feedstocks, primarily from waste and by- product agricultural sources.

GBL has an extensive portfolio of proprietary and engineered Clostridia strains used as biocatalysts to process a wide range of starch, sugar and cellulosic feedstocks.

In China, GBL has three projects underway on molasses and corn by-product feedstocks. In India and Brazil, GBL’s focus is molasses, cane and bagasse. In North America, the focus is on both starch-based and cellulosic feedstocks.

Rate this article

12345
Current rating: 0 (0 ratings)
BusMag
Angus
Marriott
BP Collins
Copyright © Elcot Publications Ltd. All rights reserved.   Web Design: Discover IT (UK) Ltd
Home   ¦   Sitemap